← Evidence map

ArticleNature cancer2025

The evolving landscape of RAS-targeted therapies.

Sandra MisalePubMed ↗Publisher ↗

No numbers read from the abstract.

Not cited yet

Full record →Abstract, authors, funding and every citing paper · PMID 41372477